Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Intermittent Pneumatic compression, Routine care · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Intermittent Pneumatic Compression | EXPERIMENTAL | SCD Express device applied with thigh length sleeves for up to 30 days |
| Routine care | OTHER | Routine care which might include: early mobilisation, adequate hydration, aspirin if ischaemic stroke and graduated compression stockings according to local protocols. |
| Name | Type | Description |
|---|---|---|
| Intermittent Pneumatic compression | DEVICE | Thigh length sleeves applied to both legs from randomization to Day 30 (Day and night) whilst sitting and lying |
| Routine care | OTHER | Routine care which might include: early mobilization, adequate hydration, aspirin if ischemic stroke and graduated compression stockings according to local protocols. |
Inclusion Criteria: * Any patient admitted to hospital within 3 days of a clinical stroke fulfilling the WHO criteria. and • Who is not able to get up from a chair/ out of bed and walk to the toilet without the help of another person Patients can be randomised from Day 0 (day of admission) to Da...
Top 20 of 24 competitors
Intermittent Pneumatic Compression is being studied for use in stroke patients to prevent post-stroke deep vein thrombosis (DVT). It is an investigational treatment evaluated in a Phase 3 clinical trial. The therapy is not yet approved and remains in clinical development.
Medtronic plc (NYSE: MDT) is developing Intermittent Pneumatic Compression. The company is conducting a Phase 3 clinical trial to evaluate its effectiveness in preventing deep vein thrombosis in stroke patients.
Intermittent Pneumatic Compression is in Phase 3 clinical development. It is an investigational therapy being studied for the prevention of deep vein thrombosis in stroke patients. It is not yet approved by regulatory authorities.
Intermittent Pneumatic Compression is studied in one completed Phase 3 trial, NCT00789542, titled 'A RCT to Establish the Effectiveness of Intermittent Pneumatic Compression to Prevent Post Stroke DVT.' The trial enrolled 2,876 participants in the United Kingdom and was completed.
Intermittent Pneumatic Compression is distinct from routine care. In the clinical trial, it was compared against routine care as a controlled intervention. The trial was randomized but not double-blinded, and it enrolled 2,876 stroke patients.